Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

166.18
-0.0200-0.01%
Post-market: 166.190.0101+0.01%19:55 EDT
Volume:7.15M
Turnover:1.19B
Market Cap:42.64B
PE:-11.69
High:166.85
Open:166.55
Low:165.27
Close:166.20
52wk High:176.60
52wk Low:141.05
Shares:256.62M
Float Shares:256.62M
Volume Ratio:0.83
T/O Rate:2.79%
Dividend:2.45
Dividend Rate:1.47%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.24
PE(LYR):-11.69

Loading ...

Needham Initiates GE Healthcare Technologies at Buy With $93 Price Target

MT Newswires Live
·
Sep 22

Buy Rating Reiterated on Foralumab Data Catalysts, $7 Price Target Maintained

TIPRANKS
·
Sep 22

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)

TIPRANKS
·
Sep 22

AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis

TIPRANKS
·
Sep 22

EPF Raises Stake in IHH Healthcare to 13.2%

TIPRANKS
·
Sep 22

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

GlobeNewswire
·
Sep 22

Observe Medical Launches New Website to Deepen Dialogue With Healthcare Decision-Makers

TIPRANKS
·
Sep 22

Analysts Are Bullish on These Healthcare Stocks: Ligand Pharma (LGND), Disc Medicine (IRON)

TIPRANKS
·
Sep 22

Health Care Roundup: Market Talk

Dow Jones
·
Sep 22

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and Siemens Healthineers AG (OtherSEMHF)

TIPRANKS
·
Sep 22

AbbVie Announces European Commission Approval of Rinvoq (Upadacitinib)

Reuters
·
Sep 22

AbbVie Says EU Approves Rinvoq for Children with Polyarticular Juvenile Idiopathic Arthritis

Reuters
·
Sep 22

Abbvie Announces European Commission Approval of Rinvoq® (Upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis

THOMSON REUTERS
·
Sep 22

Abbvie - Rinvoq Approved in EU for Pjia in Patients Aged Two Years and Older

THOMSON REUTERS
·
Sep 22

IHH Healthcare's Earnings Momentum Likely Accelerating

Dow Jones
·
Sep 22

Eli Lilly and Company Breaks Ground on $6.5 Billion Houston Manufacturing Site

MT Newswires Live
·
Sep 22

Eli Lilly: Breaks Ground on Fifth U.S. API Manufacturing Site in Houston

THOMSON REUTERS
·
Sep 22

Eli Lilly: Houston Facility to Manufacture Active Pharmaceutical Ingredients for Medicines Like Foundayo

THOMSON REUTERS
·
Sep 22

Molina Healthcare Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 22

Health Care up on Drug Breakthrough Hopes - Health Care Roundup

Dow Jones
·
Sep 22